The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3
- PMID: 10037507
- DOI: 10.1046/j.1471-4159.2000.0721327.x
The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3
Abstract
Valproic acid (VPA) is a potent broad-spectrum anti-epileptic with demonstrated efficacy in the treatment of bipolar affective disorder. It has previously been demonstrated that both VPA and lithium increase activator protein-1 (AP-1) DNA binding activity, but the mechanisms underlying these effects have not been elucidated. However, it is known that phosphorylation of c-jun by glycogen synthase kinase (GSK)-3beta inhibits AP-1 DNA binding activity, and lithium has recently been demonstrated to inhibit GSK-3beta. These results suggest that lithium may increase AP-1 DNA binding activity by inhibiting GSK-3beta. In the present study, we sought to determine if VPA, like lithium, regulates GSK-3. We have found that VPA concentration-dependently inhibits both GSK-3alpha and -3beta, with significant effects observed at concentrations of VPA similar to those attained clinically. Incubation of intact human neuroblastoma SH-SY5Y cells with VPA results in an increase in the subsequent in vitro recombinant GSK-3beta-mediated 32P incorporation into two putative GSK-3 substrates (approximately 85 and 200 kDa), compatible with inhibition of endogenous GSK-3beta by VPA. Consistent with GSK-3beta inhibition, incubation of SH-SY5Y cells with VPA results in a significant time-dependent increase in both cytosolic and nuclear beta-catenin levels. GSK-3beta plays a critical role in the CNS by regulating various cytoskeletal processes as well as long-term nuclear events and is a common target for both lithium and VPA; inhibition of GSK-3beta in the CNS may thus underlie some of the long-term therapeutic effects of mood-stabilizing agents.
Similar articles
-
Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons.Mol Cell Neurosci. 2002 Jun;20(2):257-70. doi: 10.1006/mcne.2002.1117. Mol Cell Neurosci. 2002. PMID: 12093158
-
Valproate recovers the inhibitory effect of dexamethasone on the proliferation of the adult dentate gyrus-derived neural precursor cells via GSK-3β and β-catenin pathway.Eur J Pharmacol. 2014 Jan 15;723:425-30. doi: 10.1016/j.ejphar.2013.10.060. Epub 2013 Nov 7. Eur J Pharmacol. 2014. PMID: 24211784
-
Lithium and valproate act on the GSK-3β signaling pathway to reverse manic-like behavior in an animal model of mania induced by ouabain.Neuropharmacology. 2017 May 1;117:447-459. doi: 10.1016/j.neuropharm.2016.10.015. Epub 2016 Oct 24. Neuropharmacology. 2017. PMID: 27789311
-
Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.Curr Drug Metab. 2018;19(8):663-673. doi: 10.2174/1389200219666171227203737. Curr Drug Metab. 2018. PMID: 29283064 Review.
-
Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.J Clin Psychiatry. 1999;60 Suppl 2:27-39; discussion 40-1, 113-6. J Clin Psychiatry. 1999. PMID: 10073385 Review.
Cited by
-
GSK3 Is a Central Player in Retinal Degenerative Diseases but a Challenging Therapeutic Target.Cells. 2022 Sep 16;11(18):2898. doi: 10.3390/cells11182898. Cells. 2022. PMID: 36139472 Free PMC article. Review.
-
Safety and Efficacy of Combined Low-Dose Lithium and Low-Dose Aspirin: A Pharmacological and Behavioral Proof-of-Concept Study in Rats.Pharmaceutics. 2021 Nov 1;13(11):1827. doi: 10.3390/pharmaceutics13111827. Pharmaceutics. 2021. PMID: 34834241 Free PMC article.
-
MicroRNA-dependent control of neuroplasticity in affective disorders.Transl Psychiatry. 2021 May 3;11(1):263. doi: 10.1038/s41398-021-01379-7. Transl Psychiatry. 2021. PMID: 33941769 Free PMC article. Review.
-
Modulation of Brain Hyperexcitability: Potential New Therapeutic Approaches in Alzheimer's Disease.Int J Mol Sci. 2020 Dec 7;21(23):9318. doi: 10.3390/ijms21239318. Int J Mol Sci. 2020. PMID: 33297460 Free PMC article. Review.
-
Recent Advances on the Role of GSK3β in the Pathogenesis of Amyotrophic Lateral Sclerosis.Brain Sci. 2020 Sep 26;10(10):675. doi: 10.3390/brainsci10100675. Brain Sci. 2020. PMID: 32993098 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous